{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:42:21Z","timestamp":1791020541215,"version":"4.1.0"},"reference-count":25,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2006]]},"DOI":"10.2133\/dmpk.21.222","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T06:41:18Z","timestamp":1153464078000},"page":"222-229","source":"Crossref","is-referenced-by-count":19,"title":["Excellent Absorption Enhancing Characteristics of NO Donors for Improving the Intestinal Absorption of Poorly Absorbable Compound Compared with Conventional Absorption Enhancers"],"prefix":"10.2133","volume":"21","author":[{"given":"Gihan","family":"Fetih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawsia","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemasa","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.21.222_bb0005","first-page":"25","article-title":"A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit","volume":"263","author":"Yamamoto","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.21.222_bb0010","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1211\/0022357991776976","article-title":"Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-\u03b2-D-maltopyranoside","volume":"51","author":"Uchiyama","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.21.222_bb0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.2042-7158.1983.tb04294.x","article-title":"Enhancement of rectal absorption of insulin using salicylates in dogs","volume":"35","author":"Nishihata","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.21.222_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1015930821648","article-title":"Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2 EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery","volume":"5","author":"Aungst","year":"1988","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.21.222_bb0025","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1248\/bpb.19.1618","article-title":"Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane","volume":"19","author":"Uchiyama","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.2133\/dmpk.21.222_bb0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2337\/diab.30.12.1065","article-title":"Enhanced intestinal absorption of insulin in rats in the presence of sodium 5-methoxysalicylate","volume":"30","author":"Nishihata","year":"1981","journal-title":"Diabetes"},{"key":"10.2133\/dmpk.21.222_bb0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.2042-7158.1996.tb03937.x","article-title":"Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane","volume":"48","author":"Yamamoto","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.21.222_bb0040","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1096\/fasebj.6.12.1381691","article-title":"Nitric oxide as a secretory product of mammalian cells","volume":"6","author":"Nathan","year":"1992","journal-title":"FASEB J."},{"key":"10.2133\/dmpk.21.222_bb0045","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/0016-5085(92)91454-C","article-title":"Role of nitric oxide in gastrointestinal and hepatic function and disease","volume":"103","author":"Stark","year":"1992","journal-title":"Gastroenterology"},{"key":"10.2133\/dmpk.21.222_bb0050","first-page":"G361","article-title":"Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers","volume":"268","author":"Salzman","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.2133\/dmpk.21.222_bb0055","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1023\/A:1011920530771","article-title":"Nitric oxide donors enhance rectal absorption of macromolecules in rabbits","volume":"15","author":"Utoguchi","year":"1998","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.21.222_bb0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2005.05.017","article-title":"Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats","volume":"106","author":"Fetih","year":"2005","journal-title":"J. Control. Release"},{"key":"10.2133\/dmpk.21.222_bb0065","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1023\/A:1018968611962","article-title":"Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats","volume":"11","author":"Yamamoto","year":"1994","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.21.222_bb0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jps.2600840604","article-title":"Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine","volume":"84","author":"Asada","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.21.222_bb0075","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/js9505051","article-title":"Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine","volume":"85","author":"Goto","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.21.222_bb0080","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1248\/bpb1978.9.793","article-title":"The mode of enhanced enteral absorption of macromolecules by lipid-surfactant mixed micelles. I","volume":"9","author":"Masuda","year":"1986","journal-title":"J. Pharmacobiodyn."},{"key":"10.2133\/dmpk.21.222_bb0085","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1021\/jo00058a030","article-title":"New nitric oxide-releasing zwitterions derived from polyamines","volume":"58","author":"Hrabie","year":"1993","journal-title":"J. Org. Chem."},{"key":"10.2133\/dmpk.21.222_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0076-6879(96)68030-6","article-title":"\"NONOates'' (1-substituted diazen-1-ium-1,2-dio-lates) as nitric oxide donors: convenient nitric oxide dosage forms","volume":"268","author":"Keefer","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.2133\/dmpk.21.222_bb0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/tx960183w","article-title":"Measurement and modeling of nitric oxide release rates for nitric oxide donors","volume":"10","author":"Ramamurthi","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.2133\/dmpk.21.222_bb0100","first-page":"1256","article-title":"Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols","volume":"255","author":"Kowaluk","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.21.222_bb0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1039\/cs9851400171","article-title":"S-Nitrosation and the reactions of S-nitroso compounds","volume":"14","author":"Williams","year":"1985","journal-title":"Chem. Soc. Rev."},{"key":"10.2133\/dmpk.21.222_bb0110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.2042-7158.1997.tb06041.x","article-title":"Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes","volume":"49","author":"Yamamoto","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.21.222_bb0115","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/1520-6017(200010)89:10<1296::AID-JPS7>3.0.CO;2-K","article-title":"Improvement of intestinal absorption of macromolecules by nitric oxide donor","volume":"89","author":"Numata","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.21.222_bb0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0022-3565(24)29666-X","article-title":"Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs","volume":"296","author":"Yamamoto","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.21.222_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10611860008996864","article-title":"Absorption enhancement of a protein drug by nitric oxide donor: effect on nasal absorption of human granulocyte colony-stimulating factor","volume":"8","author":"Watanabe","year":"2000","journal-title":"J. Drug Target."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715306716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715306716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:48:16Z","timestamp":1736470096000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715306716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006]]}},"alternative-id":["S1347436715306716"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.21.222","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}